Earnings call Merck reported Q4 organic sales growth of 2.6% and EBITDA pre up 3.1% organically, overcoming significant FX headwinds. Life Science and rare diseases drove performance, while ...
EMBED <iframe src="https://archive.org/embed/windows_3.11_en-de-ru-tr_with_ms-dos_6.22_eng." width="560" height="384" frameborder="0" webkitallowfullscreen="true ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results